Palvella Therapeutics (PVLA) Free Cash Flow (2016 - 2024)
Historic Free Cash Flow for Palvella Therapeutics (PVLA) over the last 12 years, with Q4 2024 value amounting to -$5.4 million.
- Palvella Therapeutics' Free Cash Flow fell 12616.32% to -$5.4 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$10.8 million, marking a year-over-year increase of 2215.66%. This contributed to the annual value of -$10.8 million for FY2024, which is 2215.66% up from last year.
- According to the latest figures from Q4 2024, Palvella Therapeutics' Free Cash Flow is -$5.4 million, which was down 12616.32% from -$2.7 million recorded in Q3 2024.
- Palvella Therapeutics' 5-year Free Cash Flow high stood at $29.7 million for Q2 2021, and its period low was -$23.0 million during Q1 2022.
- Over the past 5 years, Palvella Therapeutics' median Free Cash Flow value was -$10.9 million (recorded in 2020), while the average stood at -$7.1 million.
- Its Free Cash Flow has fluctuated over the past 5 years, first soared by 37379.83% in 2021, then plummeted by 15461.13% in 2022.
- Quarter analysis of 5 years shows Palvella Therapeutics' Free Cash Flow stood at -$14.0 million in 2020, then grew by 19.36% to -$11.3 million in 2021, then decreased by 14.5% to -$12.9 million in 2022, then soared by 258.33% to $20.5 million in 2023, then plummeted by 126.16% to -$5.4 million in 2024.
- Its Free Cash Flow was -$5.4 million in Q4 2024, compared to -$2.7 million in Q3 2024 and -$1.6 million in Q2 2024.